Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity
Titel:
Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity
Auteur:
Lampson, Benjamin L. Kasar, Siddha N. Matos, Tiago R. Morgan, Elizabeth A. Rassenti, Laura Davids, Matthew S. Fisher, David C. Freedman, Arnold S. Jacobson, Caron A. Armand, Philippe Abramson, Jeremy S. Arnason, Jon E. Kipps, Thomas J. Fein, Joshua Fernandes, Stacey Hanna, John Ritz, Jerome Kim, Haesook T. Brown, Jennifer R.